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Abstract
Background: Proper utilization of medicines is a critical component of pharmaceutical care plan. The aim of this
study was to assess drug use pattern at ten primary healthcare centers (PHCCs) of the Bahawalpur district of the
Punjab province of Pakistan by employing the WHO/INRUD core drug use indicators.
Methods: This was a descriptive, non-experimental and cross-sectional study. For the prescribing indicators, 1000
prescriptions (100 prescriptions per PHCC) were systematically sampled out of the total 290,000 prescriptions written
during January to December 2014. A total of 300 randomly selected patients (30 per PHCC) and 10 pharmacy personnel
(one per PHCC) were observed and interviewed to investigate the patient-care and facility-specific indicators, respectively.
We used published ideal standards for each of the WHO/INRUD indicators.
Results: Among the prescribing indicators, the average number of drugs per encounter was 3.4 (SD = 0.8) (optimal
range = 1.6–1.8), the drugs prescribed by the generic name were 71.6% (optimal value = 100%), the encounters with an
antibiotic prescribed were 48.9% (optimal range = 20.0–26.8%), the encounters with an injection prescribed were 27.1%
(optimal range = 13.4–24.1%) and the drugs prescribed from the Essential Drugs List (EDL) were 93.4% (optimal value =
100%). Among the patient-care indicators, the average consultation time was 2.2 min (SD = 0.8) (optimal value ≥10 min),
the average dispensing time was 38 s (SD = 12.1) (optimal value ≥90 s), the percentage of drugs actually dispensed was
90.9% (optimal value = 100%), the percentage of drugs adequately labeled was 100% (optimal value = 100%) and the
patients’ knowledge of correct dosage was 62.1% (optimal value = 100%). Among the facility-specific indicators, all PHCCs
had a copy of the EDL and the key drugs available in the stock were 82% (optimal value = 100%).
Conclusions: Irrational use of drugs was observed in all healthcare facilities. This study necessitates the need to
implement the WHO/INRUD recommended 12 core interventions to promote rational use of medicines.
Keywords: Primary healthcare center, Rational, Irrational, Use of drugs, WHO/INRUD core drug use indicators, Prescribing
pattern, Patient-care, Facility-specific, Pakistan
Background
Appropriate use of medicines is essential to provide
better health and medical care to patients and to the
community as a whole [1]. World Health Organization
(WHO) defines rational use of medicines as “patients
receive medications appropriate to their clinical needs,
in doses that meet their own individual requirements,
for an adequate period of time, and at the lowest cost to
them and their community” [2]. According to the World
Bank, in developing countries, 20–50% of the healthcare
expenditures are spent on medicines and other medical
trifles. Studies have showed that over 50% of all medi-
cines worldwide are prescribed or sold incorrectly and
50% of the patients are unable to use them correctly [3].
Irrational prescribing practices result in unsafe and inef-
fective treatment, aggravation or prolongation of disease
state, harm and distress to the patients and increased
costs [4, 5]. Irrational utilization of medicines can also
cause an increase in morbidity and mortality associated
with chronic conditions such as diabetes, hypertension,
epilepsy and neurological disorders [3]. The increase in
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antibiotic resistance due to the overuse of antibiotics is
one of the major problems of the irrational use of medi-
cines [6, 7].
Irrational use of drugs among patients is enforcing
them to lose confidence in the healthcare system. In de-
veloping countries, for example Pakistan, the problem is
exacerbated by limited economic resources and lack of
organized drug policy [5, 7]. The most common causes
of irrational medicine use are; self-medication, polyphar-
macy, inappropriate use of antibiotics, overuse of inject-
able and prescribing of medicines which are not
according to clinical practice guidelines [3, 5, 7]. Fur-
thermore, there are numerous factors that influence ir-
rational prescribing for example patients, practitioners/
physicians, the working environment, the drug supply
system, legal regulations, information and misinforma-
tion about the medicines and profit intentions from sell-
ing medicines [8–12].
The fundamental steps to limit the irrational use of
medicines is to identify the type, amount and reasons
of irrational use of medicines. In 1990’s, WHO in col-
laboration with the International Network of Rational
Use of Drugs (INRUD) developed a set of indicators
to measure the performance of healthcare facilities
related to utilization of drugs [1]. These core drug
use indicators are classified into prescribing, patient-
care and facility-specific (Table 1). Assessment of
drug use patterns through the WHO/INRUD indica-
tors have been successfully implemented in more than
30 developing countries [13].
To-date, no study from Pakistan has reported drug
use practices at the primary healthcare centers
(PHCCs) based on the standard core drug use indica-
tors. Therefore, the purpose of this study was to in-
vestigate the drug use pattern by employing the
WHO/INRUD core drug use indicators at the PHCCs
of the Bahawalpur district of the Southern Punjab,
Pakistan. The measured values could be used as
benchmarks for the healthcare facilities and as a basis
for further follow-up of quality of drug use. The find-
ings of this study will further help the policymakers
to implement appropriate interventions to promote
rational use of medicines.
Methods
Study setting
The study was conducted in the Bahawalpur district
of the Punjab province of Pakistan. Bahawalpur is the
12th largest city of Pakistan with an approximate
population of 3,333,467 people. There are two public
sector tertiary healthcare facilities in Bahawalpur.
Besides this, there are 84 PHCCs in the Bahawalpur
district. Out of these, 10 PHCCs were randomly
selected using random number generator function. All
PHCCs of Pakistan in general and the Punjab prov-
ince in specific are almost similar in terms of patient
mix and qualifications of the healthcare staff.
Study design and outcome measures
A quantitative, non-experimental and cross-sectional
study design was employed to evaluate the perform-
ance of PHCCs in three general areas related to ra-
tional drug use; prescribing, patient-care and facility.
The optimal values for prescribing [4, 5, 7], patient-
care and facility-specific indicators [5, 6, 14] were
adopted from previous studies. The optimal values for
consultation and dispensing time were set as ≥10 min
and ≥90 s, respectively.
Zhang and Zhi developed index system for the com-
prehensive evaluation of healthcare system [14, 15].
This index system has been successfully employed by
various healthcare systems for process improvement
[14, 16]. For the calculation of indices (index of non-
poly-pharmacy, index of rational antibiotic use and




All other indices (index of generic name, index of
EDL, consultation time index, dispensing time index,
index of actually dispensed drugs, index of labeling of
drugs, index of patients’ knowledge, index of EDL
Table 1 Core drug use indicators and their optimal values
Core drug use indicators Optimal values
Prescribing indicators
Average number of medicines prescribed per
patient encounter
1.6–1.8
Percent medicines prescribed by generic name 100
Percent encounters with an antibiotic prescribed 20.0–26.8
Percent encounters with an injection prescribed 13.4–24.1
Percent medicines prescribed from essential
medicines list or formulary
100
Patient-care indicators
Average consultation time (minutes) ≥10
Average dispensing time (seconds) ≥90
Percent medicines actually dispensed 100
Percent medicines adequately labeled 100
Percent patients with knowledge of correct doses 100
Facility-specific indicators
Availability of essential medicines list or formulary
to practitioners
100
Percent key medicines available 100
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availability and index of key drugs available in stock)
were calculated by the following formula;
Index ¼ Observedvalue
Optimal value
The optimal index for all indicators was set as 1. The
values closer to 1 indicated rational drug use. The Index
of Rational Drug Prescribing (IRDP) was calculated for
all healthcare centers by adding the index values of all
prescribing indicators [14]. Based on the IRDP values,
the PHCCs were ranked from 1 to 10 (rank 1 for the
higher IRDP value and rank 10 for the lower IRDP). In a
similar fashion, the Index of Rational Patient-Care Drug
Use (IRPCDU) and the Index of Rational Facility-
Specific Drug Use (IRFSDU) were calculated. Finally, the
Index of Rational Drug Supply (IRDS) was calculated for
all PHCCs by adding up the total of IRDP, IRPCDU, and
IRFSDU. Subsequently, the PHCCs were ranked based
on the IRDS indices. The PHCC with the higher IRDS
value was considered best performing PHCC in terms of
rational drug use and was given rank 1.
Data collection
The standard prescribing, patient-care and facility-specific
indicator forms were used to collect the data. Reliability of
the data was ensured by following the WHO guidelines
and methods [1]. The data was collected during the
months of January and February 2015. Trained data col-
lectors explained the purpose of the study to the respon-
dents and obtained their consent before data collection.
Prescribing indicators
For the prescribing indicators, trained data collectors
randomly selected 1000 prescriptions (100 prescrip-
tions per PHCC) out of the total 290,000 prescrip-
tions written during the period of one year (i.e.,
January to December 2014). The sample was selected
using systematic random sampling technique and the
sampling unit was the patient encounters at each of
the PHCCs [4]. To minimize the biasness arising as a
consequence of seasonal alterations or discontinuation
of supply cycle of the drugs, the encounters were uni-
formly distributed throughout the year in a way that
the whole year was divided in four quarters and 25
prescriptions were taken from each quarter. The sam-
ple was limited to the encounters comprising of acute
and chronic illnesses, indicating a mixture of health
conditions and age of the patients. Referral or vaccin-
ation cases were excluded from the study.
Patient-care indicators
For the patient-care indicators, patients visiting the
healthcare facilities for the diagnosis and treatment of
general health problems were invited to participate in
the study. A total of 300 patients (30 patients per PHCC)
comprising a mixture of disease states and age groups
were selected in a uniform manner throughout the clinic
hours. The consented patients were observed and inter-
viewed to obtain the required information.
Facility-specific indicators
In general, pharmacy personnel (not necessarily a
pharmacist) dispense the drugs to the patients at the
pharmacy counter of each PHCC. For the facility-
specific indicators, one personnel per PHCC was
selected and the consented respondents were inter-
viewed to obtain the required information.
Statistical analysis
Statistical Package for Social Sciences (IBM SPSS Statistics
for Windows, version 21.0, Armonk, NY: IBM Corp.) was
used for analysis of data. Descriptive statistics such as
frequencies, percentages, mean and standard deviation
were measured. Differences among the healthcare facilities
were established using ANOVA test. The statistical signifi-
cance was determined by p < .05.
Note: In this paper, the word ‘drug(s)’ and ‘medicine(s)’




The average number of drugs per encounter was 3.4
(SD = 0.8) while 71.6% (SD = 15.7) drugs were prescribed
by the generic name. The percentage of encounters with
an antibiotic was 48.9% (SD = 20.2). The percentage of
encounters with an injection was 27.1% (SD = 9.8). The
percentage of drugs prescribed from the EDL was 93.4%
(SD = 7.1). The difference among the PHCCs was statis-
tically significant for all prescribing indicators (Table 2).
Patient-care indicators
The average consultation time was 2.2 (SD = 0.8) minutes.
The average dispensing time was 38 (SD = 12.1) seconds.
90.9% (SD = 9.5) of the prescribed drugs were actually dis-
pensed. All dispensed drugs were adequately labeled. The
percentage of patients’ knowledge of the correct dosage
was 62.1 (SD = 19). The difference among the PHCCs was
statistically significant for all patient-care indicators except
the percentage of drugs adequately labeled (Table 3).
Facility-specific indicators
The percentage availability of the EDL copy was
100% (SD = 0.0) and of key drugs in the stock was
82% (SD = 7.9). Among the PHCCs, there was a sig-
nificant difference for all facility-specific indicators
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except the percentage availability of the EDL copy
(Table 3).
The IRDP values showed that the PHCC number six
was performing well with regard to rational prescribing
practices. Similarly, the IRPCDU values indicated that
the PHCC number nine showed better results among all
PHCCs with regard to patient-care indicators. The
PHCC number one, four, eight and nine showed com-
parable better results with regard to facility-specific indi-
cators. Overall, the IRDS values showed that the PHCC
number nine was performing well among other PHCCs
in terms of rational drug use (Table 4).
Discussion
The irrational prescribing practices exist all over the
world and ultimately lead to unwanted effects in patients
[6]. In this study, the WHO/INRUD drug use indicators
were used to identify current treatment practices that
may help to resolve problems regarding drug therapy.





Average number of medicines










from essential medicines list
1 3.4 (1.4) 81.2 64.0 38.0 98.5
2 3.6 (1.5) 85.1 63.0 32.0 87.6
3 3.4 (1.3) 83.0 87.0 21.0 89.2
4 3.2 (3.1) 43.7 40.0 18.0 90.7
5 3.2 (1.4) 88.5 56.0 30.0 100
6 1.9 (1.0) 50.0 31.0 25.0 100
7 5.0 (2.3) 60.0 30.0 9.0 80.5
8 4.3 (2.4) 76.0 28.0 28.0 100
9 2.9 (0.7) 66.7 29.0 43.0 100
10 3.4 (1.1) 82.0 61.0 27.0 87.9
Mean (SD) 3.4 (0.8) 71.6 (15.7) 48.9 (20.2) 27.1 (9.8) 93.4 (7.1)
ANOVA p < .0005 p < .0005 p < .0005 p < .0005 p < .0005
a1 = Agha pur, 2 = Jamal channar, 3 = Mubarak pur, 4 = Jhangi wali, 5 = Mithra, 6 = Chak katoora, 7 = Kud wala, 8 = Khanqah sharif, 9 = Khanu wali, 10 = Kulaab

























1 2.3 (1.5) 43.1 (34.7) 87.3 100.0 67.0 100.0 90.0
2 2.5 (1.2) 43.0 (17.1) 91.1 100.0 77.0 100.0 70.0
3 2.4 (1.0) 36.7 (10.8) 91.2 100.0 77.0 100.0 80.0
4 0.7 (0.4) 15.5 (7.7) 100.0 100.0 30.0 100.0 90.0
5 2.1 (0.8) 42.6 (16) 85.8 100.0 67.0 100.0 80.0
6 1.3 (0.6) 31.3 (14) 68.3 100.0 33.0 100.0 80.0
7 2.9 (1.4) 30.9 (10.5) 100.0 100.0 53.0 100.0 70.0
8 2.1 (1.2) 36.9 (25.8) 91.5 100.0 64.0 100.0 90.0
9 3.6 (1.1) 63.3 (50.7) 100.0 100.0 90.0 100.0 90.0
10 2.1 (1.0) 37.1 (20.6) 93.6 100.0 63.0 100.0 80.0
Mean (SD) 2.2 (0.8) 38.0 (12.1) 90.9 (9.5) 100.0 62.1 (19) 100.0 82.0 (7.9)
ANOVA p < .0005 p < .0005 p < .0005 ————a p < .0005 ————a p < .0005
aANOVA was not applied for these indicators as there was no variation in their values
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Our findings would also be a source of baseline informa-
tion for continuous monitoring of drug therapy.
A number of developing and transitional countries
have conducted similar studies. Ten previously published
studies from different countries were reviewed and
included for comparison purposes (Table 5).
Prescribing indicators
A prescription is the reflection of prescribers’ attitude
towards the disease being treated and type of healthcare
system in the country. The results of this study revealed
that the average number of drugs per encounter was 3.4
(SD = 0.8), and the difference among the PHCCs was
statistically significant (p ≤ 0.0005). Our value is higher
than the admissible range of 1.6–1.8 drugs per encoun-
ter. In contrast to our findings, the average number of
drugs per encounter was lower in a majority of develop-
ing countries (range = 1.3–3.0). For example, this value
was 3.0 in Sri Lanka [17], 2.1 in Nepal [18], 2.2 in
Vietnam [19], 2.3 in Botswana [20], 2.3 in Burkina Faso
[21], 1.8 in Malawi [22], 1.4 in Sudan [23] and 1.3 in
Zimbabwe [24]. However, the average number of drugs
per encounter was higher in Afghanistan (3.9) [25], India
(5.6) [26], Ghana (4.8) [27] and Nigeria (5.2) [28]. Sev-
eral reasons might be responsible for higher number of
drugs in a prescription. For example, incompetency on
the part of physicians, unavailability of clinical practice
guidelines, financial incentives to the prescribers, lack of
continuous medical education of the prescribers and the
shortage of therapeutically correct drugs [5]. Polyphar-
macy can adversely influence the treatment outcomes as
the patients are more likely to be non-compliant and are
at higher risk of adverse events. Moreover, unnecessarily
prescribed medicines may lead to fiscal implications for
national healthcare systems [5, 7].
There are high recommendations of WHO for generic
prescription [29]. WHO deems it as a safety measure for
patients as it clearly depicts and gives easy accessible in-
formation, and leads to better communication among
healthcare providers [6]. The results revealed that the
Table 4 Performance indicators for selected primary healthcare centers of the Bahawalpur district, Punjab, Pakistan
Performance Indicators Primary Healthcare Centers
1 2 3 4 5 6 7 8 9 10
Prescribing Indicators
(1) Non-polypharmacy index 0.53 0.5 0.53 0.56 0.56 0.95 0.36 0.42 0.62 0.53
(2) Generic name index 0.81 0.85 0.83 0.44 0.88 0.50 0.60 0.76 0.67 0.82
(3) Rational antibiotic index 0.42 0.43 0.31 0.67 0.48 0.86 0.89 0.96 0.92 0.44
(4) Injection safety index 0.63 0.75 1.0 1.0 0.80 0.96 1.0 0.86 0.56 0.89
(5) Essential drugs list index 0.99 0.88 0.89 0.91 1.0 1.0 0.81 1.0 1.0 0.88
IRDP 3.38 3.41 3.56 3.58 3.72 4.27 3.66 4.0 3.77 3.56
Rank 9 8 7 6 4 1 5 2 3 7
Patient-Care Indicators
(6) Consultation time index 0.23 0.25 0.24 0.07 0.21 0.13 0.29 0.21 0.36 0.21
(7) Dispensing time index 0.48 0.48 0.41 0.17 0.47 0.35 0.34 0.41 0.70 0.41
(8) Dispensed drugs index 0.87 0.91 0.91 1.0 0.85 0.68 1.0 0.91 1.0 0.93
(9) Labeled drugs index 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
(10) Patients’ knowledge index 0.67 0.77 0.77 0.30 0.67 0.33 0.53 0.64 0.90 0.63
IRPCDU 3.25 3.41 3.33 2.54 3.20 2.49 3.16 3.17 3.96 3.17
Rank 4 2 3 8 5 9 7 6 1 6
Facility-Specific Indicators
(11) Index of EDL 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
(12) Index of key drugs in stock 0.90 0.70 0.80 0.90 0.80 0.80 0.70 0.90 0.90 0.80
IRFSDU 1.90 1.70 1.80 1.90 1.80 1.80 1.70 1.90 1.90 1.80
Rank 1 3 2 1 2 2 3 1 1 2
Grand total
IRDS 8.53 8.52 8.69 8.02 8.72 8.56 8.52 9.07 9.63 8.53
Rank 6 7 4 8 3 5 7 2 1 6
Optimal index = 1, IRDP Index of Rational Drug Prescribing, IRPCDU Index of Rational Patient-Care Drug Use, EDL Essential Drugs List, IRFSDU Index of Rational
Facility-Specific Drug Use, IRDS Index of Rational Drug Supply
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percentage of drugs prescribed by the generic name was
71.6% (SD = 15.7). The difference among the PHCCs was
statistically significant (p ≤ 0.0005) (Table 2). The pro-
posed optimal value of drugs prescribed by the generic
name is 100% (Table 1). In a majority of developing
countries, this value was <40%, for example, in Andorra
6% [30], Uzbekistan 38.3% [31], Ecuador 37% [24],
Yemen 39.2% [32], Palestine 5.5% [33], Lebanon 2.9%
[34] and India 11.5% [35]. In a few countries, this value
was near the optimal level as reported in Cambodia
(99.8%) [36], Timor-Leste (92%) [37] and Ethiopia
(98.7%) [4]. Discrepancy among the findings of various
studies might be associated with several reasons such as
faith of prescribers on branded products, extensive
promotional activities of pharmaceutical companies in-
fluencing prescribers’ decisions or lack of legal binding
to prescribe generic medicines.
The results showed that the percentage of encoun-
ters with an antibiotic prescribed was 48.9% and the
difference among the PHCCs was statistically signifi-
cant (p ≤ 0.0005). The proposed optimal range for an
antibiotic prescribed is 20.0–26.8% (Table 1). In a ma-
jority of developing countries, the percentage of en-
counters with an antibiotic prescribed lies between
24% and 50% as in Bangladesh 25% [38], India 44.8%
[39], Nepal 43% [18], Lao People’s 47% [40], Burkina
Faso 33.1% [21], Burundi 50% [40], Tanzania 35.4% [41],
Brazil 28.8% [40] and Ethiopia 24.9% [42]. In a few coun-
tries, this value was much higher for example in Timor-
Leste 70% [37], Burma 76% [43], Kenya 73.4% [40] and
Sudan 70.4% [40]. Irrational prescription of antibiotics is a
universal problem that ultimately leads to adverse drug re-
actions and frequent hospital admissions [6]. Overuse and
misuse of antibiotics is alarming situation regarding
population health, especially in developing countries. In
our setting, there was lack of laboratory facilities to per-
form microbiological testing. This could affect prescribers’
behaviour, and consequently they may have increased ten-
dency to prescribe broad spectrum antibiotics to cover
suspected infections. Unavailability of clinical practice
guidelines, incompetency of the physicians and cultural
beliefs in a community could be a few other reasons asso-
ciated with over prescribing of antibiotics.
The present study revealed that the percentage of
encounters with an injection prescribed was 27.1% and
the difference among the PHCCs was significant (p ≤
0.0005) (Table 2). The proposed optimal range for an in-
jection prescribed is 13.4–24.1% (Table 1). In contrast to
our findings, the percentage of encounters with an injec-
tion prescribed was 17% in Afghanistan [25], 18% in Lao
People’s [44], 9% in Botswana [20], 10% in Burundi [40]
and 9.1% in Kuwait [45]. However, in some countries,
the percentage of encounters with an injection pre-
scribed was even higher than our findings for example,
45.8% in India [35], 57.6% in Cambodia [40], 41.8% in
Cameroon [46] and 80% in Ghana [27]. An excessive use
of injections, in case appropriate oral dosage forms are
available, may lead to higher probability of blood borne
diseases [3]. Moreover, injections are always costlier than
the oral formulations [6]. Limited availability of alterna-
tive modes of therapy for young children, and attitudes
and beliefs of healthcare providers and patients are a few
reasons associated with the use of injectable. In Pakistani
rural culture, patients sometimes themselves compel the
physicians to prescribe injectable with a belief that this
dosage form provides quick and complete relief. The
percentage of drugs prescribed from the EDL/formulary
was 93.4% and the difference among the PHCCs was
Table 5 Results of WHO/INRUD Indicator studies in different countries
Performance Indicators Study Reference Mean
[54] [14, 58] [55] [6] [41] [28] [48] [42] [36] [49]
Average number of medicines prescribed per patient encounter 2.2 2.4 2.3 2.5 2.3 3.0 2.2 2.2 2.4 3.1 2.5
Percent medicines prescribed by generic name 74.0 61.2 5.1 95.4 75.5 63.1 99.0 79.4 99.8 10.1 66.3
Percent encounters with an antibiotic prescribed 37.0 32.2 60.9 39.2 35.4 54.2 43.0 24.9 66.0 33.0 42.6
Percent encounters with an injection prescribed 11.0 2.0 1.2 9.9 19.0 38.0 18.0 10.6 2.4 2.4 11.4
Percent medicines prescribed from EML 78.0 99.2 93.0 95.4 87.1 75.6 98.8 90.3 99.7 65.2 88.2
Average consultation time (minutes) 5.8 7.3 3.9 7.1 3.6 6.1 3.7 6.2 4.4 2.3 5.0
Average dispensing time (seconds) 17.0 100 28.8 47.4 39.9 18.1 37.0 78.0 234 258 85.8
Percent medicines actually dispensed 66.0 99.6 81.8 95.9 91.6 99.1 84.5 83.4 100 81.0 88.3
Percent medicines adequately labeled 63.0 10.0 91.4 0.0 87.6 55.9 86.2 70.1 0.0 99.4 56.4
Percent patients with knowledge of correct doses 54.0 79.3 77.7 94.0 96.1 86.5 81.7 72.1 55.0 74.3 77.1
Availability of EML to practitioners 50.0 90.0 100 80.0 100 100 100 50.0 100 100 87
Percent key medicines available 55.0 59.2 80.0 78.3 100 91.7 86.5 65.0 86.6 84.0 78.6
EML Essential Medicines List; Study number 29 was in Brazil; 14,30 in Saudi Arabia; 31in Jordan; 6 in Egypt; 32 in Tanzania; 28 in Swaziland; 33 in Mozambique; 34
in Ethiopia; 35 in Cambodia; 36 in India
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significant (p ≤ 0.0005) (Table 2). The proposed optimal
value for the percentage of drugs prescribed from the
EDL/formulary is 100% (Table 1). The findings of our
study are comparable to other studies conducted in China
(95%) [47], Bangladesh (85%) [38], Nepal (86%) [18],
Burma (94.8%) [43], Mali (94.6%) [40], Mozambique
(98.8%) [48] and Colombia (94.2%) [40]. Rational prescrib-
ing means to prescribe drugs from the EDL issued by
WHO because medicines in EDL are older, already tested
in practice with established clinical use, and are of lower
cost than the newer drugs [6]. However, physicians may
choose non EDL drugs due to inadequate supply of the
EDL drugs.
Patient-care indicators
The results of current study demonstrated that the average
consultation time was 2.2 min (optimal time ≥ 10 min), and
the difference among the PHCCs was statistically significant
(p ≤ 0.0005) (Table 3). The short consultation time reported
in our study could be correlated with a large number of pa-
tients per physician. Such a short consultation time has cor-
respondence with the values measured in other developing
countries for example, Malawi 2.5 min [22], India 2.3 min
[49], Bangladesh 1.0 min [24], Indonesia 3.0 min [24],
Ethiopia 2.9 min [50] and Kuwait 2.8 min [45]. However,
there are certain studies conducted in China (9.5 min) [51],
Nigeria (11.3 min) [52] and Sweden (22.5 min) [53] which
reported better consultation time. According to WHO, in-
sufficient consultation time leads to incomplete patient
examination and subsequent irrational therapy [6]. Consult-
ation time within optimal range is considered sufficient for
proper history taking, complete physical examination,
appropriate health education and a good physician–patient
interaction. Short consultation time could be the conse-
quence of increased work load of the physicians, and
ethnic, religious or socioeconomic barriers between pa-
tients and healthcare providers.
The study reported an average dispensing time of 38 s
(optimal value ≥90 s). The difference among the PHCCs
was statistically significant (p ≤ 0.0005) (Table 3). This
finding is almost comparable to the findings from Brazil
(17 s) [54], Jordan (28.8 s) [55], Swaziland (18.1 s) [28],
Nigeria (12.5 s) [56], Mozambique (37 s) [48], China (25 s)
[57] and Bangladesh (23 s) [38]. However, dispensing time
was higher in Nepal (86.1 s) [18], Ethiopia (78 s) [42] and
Saudi Arabia (99.6 s) [58]. Shorter dispensing time is in-
sufficient for adequate labeling, and to provide complete
information about drug regimen, un-wanted drug effects
and precautions of drugs. Insufficient information about
therapy could lead to non-compliance and subsequent
adverse events. In our setting, shorter dispensing time was
related to higher patient load. Moreover, as the pharmacy
staff was non-pharmacist, therefore, they had limited
scope to counsel the patients which resulted in a shorter
dispensing time.
The percentage of drugs actually dispensed was 90.9%
(optimal value 100%) and the difference among the
PHCCs was statistically significant (p ≤ 0.0005). Our
value is higher than reported in Brazil (66%) [54], Jordan
(81.8%) [55], Tanzania (56.2%) [59], Nigeria (85.3%) [52],
Ethiopia (83.4%) [42] and Nepal (83%) [18]. However,
the studies from Saudi Arabia (99.6%) [14], Kuwait
(97.9%) [45], Egypt (95.9%) [6], Swaziland (99.1%) [28]
and Niger (100%) [60] reported even higher values. The
main reason involved in the low percentage of actually
dispensed drugs could be inadequate availability of drugs
in the stock. WHO recommends that dispensed drugs
should be adequately labeled with respect to patient’s
name, dose of the drug and regimen [1]. Our findings
revealed that drug labeling practice was 100% which is
good omen. In Saudi Arabia, it represented 10% [58], in
China 95% [57], in Cambodia 0.0% [36], in Swaziland
55.9% [28], in Tanzania 20.1% [59] and in Kuwait it was
66.9% [45].
According to our findings, patient’s knowledge of correct
dose was 62.1% (optimal value 100%). It was higher than
that reported in Brazil (54%) [54], Kuwait (26.9%) [45],
Tanzania (37.9%) [59], Malawi (27%) [22] and Cambodia
(55%) [36]. However, relatively better values were reported
in studies from Bangladesh (82%) [24], Nigeria (93%) [52]
and Egypt (94%) [6]. Patient’s knowledge about correct dos-
age is highly significant to avoid over use and abuse of
drugs, and prevent adverse events that ultimately affect
patient’s health. As per our understanding, limited drug-
related knowledge of the patients could be associated with
increased workload of the healthcare providers, poor
understanding skills of the patients and unavailability of
qualified pharmacists at the pharmacies.
Facility-specific indicators
The study revealed that all PHCCs had a copy of EDL/for-
mulary which is in line with the proposed norms (optimal
value 100%). However, the percentage of key drugs in the
stock were 82% (optimal value 100%). Limited availability
of key drugs might be associated with budgetary con-
straints, inadequate drug supply system or poor inventory
management of the responsible staff. Contrary to our find-
ings, studies from Saudi Arabia (90%) [58], Brazil (50%)
[54], Egypt (80%) [6], Ethiopia (50%) [42] and Bangladesh
(16%) [38] reported that a copy of EDL was not available
at all healthcare centers. Similarly, with regard to percent-
age availability of key drugs in stock, studies from Brazil
(55%) [54], Saudi Arabia (59.2%) [58], Nigeria (62%) [56],
Malawi (67%) [22], Ethiopia (65%) [42] and Bangladesh
(54%) [38] showed lower values. However, findings from
Jordan (80%) [55] and Egypt (78.3%) [6] were almost com-
parable to our findings. Some countries even reported
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better values for the percentage availability of key drugs
in stock for example, Tanzania (100%) [41], Swaziland
(91.7%) [28], Nigeria (90.9%) [28], Cambodia (86.6%)
[36] and Nepal (90%) [18]. Shortage of the essential
drugs is disadvantageous for patients in terms of their
health and out-of-pocket expenditures [6]. To ensure
proper healthcare, WHO recommends that physicians
should be adherent to the drugs listed in the EDL/for-
mulary while prescribing.
Conclusion and recommendations
This study demonstrated irrational drug use practices in all
healthcare facilities. The observed values for all INRUD in-
dicators deviated from the established norms. However,
medicines were adequately labeled and the EDL was avail-
able at all healthcare facilities. Based on these findings, it is
recommended that there should be continuous education
and training of physicians about rational prescribing of an-
tibiotics and injections. Physicians should also be motivated
to enhance generic prescribing and prescribing from the
EDL/Formulary. Patient-to-physician ratio should be
decreased for the prolongation of consultation time, which
allows thorough history taking, comprehensive examination
and development of therapeutic relationship between
patient and physician. Further, we recommend that phar-
macists should be appointed at all PHCCs for proper
dispensing of medicines and improvement of patients’
knowledge about drugs. Availability of key drugs in stock
should be improved to ensure effective treatment of general
health-related problems.
Limitations
These findings could not be generalized for Pakistan.
However, based on the fact that a uniform healthcare pol-
icy is implemented throughout, and medical graduates
from various institutions are working in the Bahawalpur
district, the practices could be assumed almost similar to
other districts of Pakistan. In this study, we did not find
the reasons of irrational drug use, which could be consid-
ered in future studies.
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